Literature DB >> 23206468

Increased serum interleukin-34 in patients with coronary artery disease.

Zhenglong Li1, Daoqun Jin, Yongbo Wu, Kai Zhang, Peng Hu, Xuemin Cao, Zhiqiang Chen.   

Abstract

OBJECTIVE: This study investigated levels of interleukin (IL)-34, a proinflammatory cytokine, in patients with coronary artery disease (CAD).
METHODS: Following coronary artery angiography, 91 patients with CAD (including stable and unstable angina pectoris) were divided into two groups, the CAD group (coronary artery stenosis ≥ 50%) and the control group (coronary artery stenosis < 50%). Serum levels of factors including IL-34 and high sensitivity C-reactive protein (hs-CRP) were measured.
RESULTS: IL-34 and hs-CRP levels were significantly higher in the CAD group than in the control group (191.3 ± 17.9 pg/ml versus 125.4 ± 14.8 pg/ml and 3.08 ± 1.81 mg/ml versus 1.42 ± 1.01 mg/ml, respectively), with a significantly positive correlation between IL-34 and hs-CRP levels in the CAD group. Multiple regression analysis showed that IL-34 and hs-CRP levels were independent predictors of CAD (IL-34: odds ratio [OR] 2.073, 95% confidence intervals (CI) 1.419, 2.672; hs-CRP: OR 1.878, 95% CI 1.172, 2.531).
CONCLUSIONS: IL-34 levels were significantly increased in patients with CAD, and positively correlated with hs-CRP levels, suggesting that IL-34 may be an independent predictor of CAD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206468     DOI: 10.1177/030006051204000525

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  10 in total

1.  Interleukin-34 induces monocytic-like differentiation in leukemia cell lines.

Authors:  Burthia E Booker; Ryan S Clark; Samuel T Pellom; Samuel E Adunyah
Journal:  Int J Biochem Mol Biol       Date:  2015-03-20

2.  Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis.

Authors:  Sung Hae Chang; Byoong Yong Choi; Jungbum Choi; Jong Jin Yoo; You-Jung Ha; Hyon Joung Cho; Eun Ha Kang; Yeong Wook Song; Yun Jong Lee
Journal:  Rheumatol Int       Date:  2014-06-11       Impact factor: 2.631

3.  IL-34 is associated with the presence and severity of renal dysfunction and coronary artery disease in patients with heart failure.

Authors:  Qin Fan; Xiaoxiang Yan; Hang Zhang; Lin Lu; Qi Zhang; Fang Wang; Rui Xi; Jian Hu; Qiujing Chen; Wenquan Niu; Weifeng Shen; Ruiyan Zhang; Rong Tao
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

4.  Prognostic Significance of Interleukin-34 (IL-34) in Patients With Chronic Heart Failure With or Without Renal Insufficiency.

Authors:  Rong Tao; Qin Fan; Hang Zhang; Hongyang Xie; Lin Lu; Gang Gu; Fang Wang; Rui Xi; Jian Hu; Qiujing Chen; Wenquan Niu; Weifeng Shen; Ruiyan Zhang; Xiaoxiang Yan
Journal:  J Am Heart Assoc       Date:  2017-04-01       Impact factor: 5.501

5.  Increased Serum Interleukin-34 Levels Are Related to the Presence and Severity of Cardiac Dysfunction in Patients With Ischemic Cardiomyopathy.

Authors:  Rui Xi; Qin Fan; Xiaoxiang Yan; Hang Zhang; Hongyang Xie; Gang Gu; Yan Xu; Fang Wang; Rong Tao
Journal:  Front Physiol       Date:  2018-07-11       Impact factor: 4.566

6.  IL-34 promotes foam cell formation by enhancing CD36 expression through p38 MAPK pathway.

Authors:  Qingyan Liu; Jiao Fan; Jing Bai; Liang Peng; Tao Zhang; Lei Deng; Gaokun Wang; Yu Zhao; Jingguo Nong; Minghua Zhang; Yu Wang
Journal:  Sci Rep       Date:  2018-11-26       Impact factor: 4.379

7.  Effect of IL-34 on T helper 17 cell proliferation and IL-17 secretion by peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  Xin Li; Yimeng Lei; Ziyu Gao; Bei Zhang; Liping Xia; Jing Lu; Hui Shen
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

8.  Bioinformatics and Experimental Analyses Reveal Immune-Related LncRNA-mRNA Pair AC011483.1-CCR7 as a Biomarker and Therapeutic Target for Ischemic Cardiomyopathy.

Authors:  Qiao Jin; Qian Gong; Xuan Le; Jin He; Lenan Zhuang
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

Review 9.  Immunomodulation of Interleukin-34 and its Potential Significance as a Disease Biomarker and Therapeutic Target.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2019-07-20       Impact factor: 6.580

10.  Emerging roles of IL-34 in health and disease.

Authors:  Iva Lelios; Dilay Cansever; Sebastian G Utz; Wiebke Mildenberger; Sebastian A Stifter; Melanie Greter
Journal:  J Exp Med       Date:  2020-03-02       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.